Charles River Laboratories | CRL - Despesa De Juros Sobre A Dívida

Preço das Ações
159.83
Mudança Diária
3.80 2.44%
Mensal
-13.51%
Anual
17.87%
Q2 Previsão
147.82




Despesa De Juros Sobre A Dívida Alterar Data
Agilent USD 25M 2M 2025-12
Align Technology USD 16.04M 14.04M 2025-12
Bio-Rad Laboratories USD 12.1M 200K 2025-12
Bruker USD 8.1M 11.9M 2025-12
Cardinal Health USD 101M 13M 2026-03
Charles River Laboratories USD 26.74M 2.97M 2026-03
Cigna USD 153.27B 4.65B 2026-03
Concord Medical Services Hldg CNY 84.37M 32.34M 2023-06
CVS Health USD 774M 13M 2026-03
Danaher USD 63M 8M 2026-03
Dentsply International USD 24M 2M 2026-03
Elevance Health USD 357M 9M 2026-03
Humana USD 193M 47M 2026-03
Illumina USD 26M 1000K 2025-12
Incyte USD 569K 13K 2026-03
Intrexon USD 2K 5K 2024-06
IQVIA Holdings USD 192M 1000K 2026-03
Laboratory Of America USD 55.1M 100K 2026-03
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Lonza CHF 84M 14M 2025-06
McKesson USD 63M 11M 2025-12
Merck EUR 104M 17M 2026-03
Mettler Toledo International USD 17.39M 307K 2025-12
Novartis USD 343M 39M 2026-03
Pfizer USD 671M 40M 2026-03
Quest Diagnostics USD 69M 2M 2025-09
Revvity USD 24.72M 1.2M 2026-03
Thermo Fisher Scientific USD 354M 11M 2026-03
United Therapeutics USD 3.1M 100K 2025-12
UnitedHealth USD 955M 19M 2026-03
Veradigm USD 1.25M 641K 2022-09
Waters USD 42M 33.38M 2026-03
West Pharmaceutical Services USD 1.9M 1.7M 2026-03